Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025

Rhea-AI Summary

Accuray (NASDAQ: ARAY) will report first quarter fiscal 2026 financial results for the period ended September 30, 2025 on November 5, 2025. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET that day.

Dial-in numbers: 1-833-316-0563 (USA) or 1-412-317-5747 (international). A dial-up replay will be available about one hour after the call for one week at 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID 7403898. A live webcast and replay will be available in the Investor Relations section at investors.accuray.com and will remain until Accuray announces second quarter fiscal 2026 results.

News Market Reaction

-4.52%

1 alert

-4.52% News Effect

On the day this news was published, ARAY declined 4.52%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MADISON, Wis., Oct. 28, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on November 5, 2025.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 7403898.

A live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the second quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor Contact
Aman Patel, CFA
Investor Relations, ICR Healthcare
aman.patel@icrhealthcare.com 

Media Contact
Beth Kaplan
Public Relations Director, Accuray
bkaplan@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-first-quarter-fiscal-2026-financial-results-on-november-5-2025-302596279.html

SOURCE Accuray Incorporated

FAQ

When will Accuray (ARAY) report Q1 fiscal 2026 results?

Accuray will report Q1 fiscal 2026 results on November 5, 2025 for the period ended September 30, 2025.

What time is the Accuray (ARAY) earnings call on November 5, 2025?

The earnings call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET on November 5, 2025.

How can investors join the Accuray (ARAY) conference call?

Dial 1-833-316-0563 (USA) or 1-412-317-5747 (international), or listen via the live webcast at investors.accuray.com.

Is there a replay for the Accuray (ARAY) Q1 2026 call and how long is it available?

A dial-up replay will be available for one week beginning about one hour after the call; webcast replay remains available until Accuray announces Q2 fiscal 2026 results.

What is the conference ID for the Accuray (ARAY) replay?

The replay conference ID is 7403898 and US replay number is 1-855-669-9658.